Résultats de la recherche
10
Tout
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
24 mars 2025 16h05 HE
|
OncoCyte Corporation
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
18 mars 2025 16h05 HE
|
OncoCyte Corporation
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
11 févr. 2025 08h30 HE
|
OncoCyte Corporation
Oncocyte to Participate in BTIG MedTech, Digital Health,
Life Science & Diagnostic Tools Conference
Oncocyte Prices $29.1 Million Equity Offering
10 févr. 2025 08h30 HE
|
OncoCyte Corporation
Oncocyte Prices $29.1 Million Equity Offering
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
08 janv. 2025 08h30 HE
|
OncoCyte Corporation
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
06 janv. 2025 16h05 HE
|
OncoCyte Corporation
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
09 déc. 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04 déc. 2024 16h15 HE
|
OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
12 nov. 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
06 nov. 2024 16h45 HE
|
OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12